Management of Neurologic Diseases in Pregnancy, Delivery, and the Postpartum Period

  • Charles E. Argoff
Part of the Current Clinical Neurology book series (CCNEU)


Women experience dramatic physiologic changes during pregnancy, birth and delivery, and the postpartum period. Although it seems obvious that the management of pregnancy can be complex in a woman with a chronic neurologic disorder, surprisingly little has been written about the subject. This chapter has been organized to review available information regarding gestation, birth and delivery, and the puerperium in women with the following neurologic conditions: cerebrovascular disease, paraplegia, migraine headache, low back pain, epilepsy, movement disorders, traumatic brain injuries, multiple sclerosis, neuromuscular disease, and neoplastic disease affecting the central nervous system.


Multiple Sclerosis Pregnant Woman Traumatic Brain Injury Carpal Tunnel Syndrome Postpartum Period 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium: a study of 135 patients. Angiology 1983; 34: 731–746.PubMedCrossRefGoogle Scholar
  2. 2.
    Wiebers D, Whisnant J. The incidence of stroke among pregnant women in Rochester, Minn., 1955–1979. JAMA 1985; 254: 3055–3057.PubMedCrossRefGoogle Scholar
  3. 3.
    Cross J, Castro P, Jennett W. Cerebral strokes associated with pregnancy and the puerperium. Br. Med. J. 1968; 3: 214–218.Google Scholar
  4. 4.
    Wiebers D. Ischemic cerebrovascular complications of pregnancy. Arch. Neurol. 1985; 42: 1106–1113.PubMedCrossRefGoogle Scholar
  5. 5.
    Wilterdink JL, Easton JD. Cerebral ischemia. In: Devinsky O, Feldman E, Hainline B (eds.), Neurological Complications of Pregnancy. New York: Raven, 1994, pp. 1–11.Google Scholar
  6. 6.
    Hart RG, Miller VT. Cerebral infarction in young adults: a practical approach. Stroke 1983; 14: 110–114.Google Scholar
  7. 7.
    Finley B. Acute coagulopathy in pregnancy. Med. Clin. North Am. 1989; 43: 553–560.Google Scholar
  8. 8.
    Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants and pregnancy. Circulation 1984; 70s I: 169–177.Google Scholar
  9. 9.
    Lavin J, Shaup T. Cardiac drugs during pregnancy. In: Rayburn W, Zuspan F (eds.), Drug Therapy in Pregnancy, 3rd ed. St. Louis: Mosby-Year Book, 1990, pp. 190–208.Google Scholar
  10. 10.
    Spearing G, Fraser I, Turner G, Dixon G. Long-term self-administered subcutaneous heparin in pregnancy. Br. Med. J. 1978; 3: 1457–1458.Google Scholar
  11. 11.
    Ginsberg J, Hirsh J. Anticoagulants during pregnancy. Ann. Rev. Med. 1989; 40: 79–86.Google Scholar
  12. 12.
    Donaldson J. Cerebrovascular disease. In: Neurology of Pregnancy, 2nd ed. London, WB Saunders, 1989, pp. 137–184.Google Scholar
  13. 13.
    Briggs G, Bondendorfer T, Freeman R. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore: Williams and Wilkins, 1983.Google Scholar
  14. 14.
    Wong C, Giuliani M, Haley E. Cerebrovascular disease and stroke in women. Cardiology 1990; 77 (Suppl 2): 80–90.PubMedCrossRefGoogle Scholar
  15. 15.
    Horton J, Chambers W, Lyons S, Adams R, Kjellberg R. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1990; 27: 867–872.PubMedCrossRefGoogle Scholar
  16. 16.
    Maymon R, Fejgin M. Intracranial hemorrhage during pregnancy and the puerperium. Obstet. Gynecol. Surv. 1990: 45: 157–159.PubMedCrossRefGoogle Scholar
  17. 17.
    Barno A, Freeman D. Maternal deaths due to spontaneous subarachnoid hemorrhage. Am. J. Obset. Gynecol. 1976; 125: 384–392.Google Scholar
  18. 18.
    Pedersen H, Finster M. Anesthetic risk in the pregnant surgical patient. Anesthesiology 1979; 51: 439–451.PubMedCrossRefGoogle Scholar
  19. 19.
    Mashini I, Albazzaz S, Fadel H. Serial noninvasive evaluation of cardiovascular hemodynamics during pregnancy. Am. J. Obstet. Gynecol. 1987; 156: 1208–1213.PubMedGoogle Scholar
  20. 20.
    Metcalfe J, McAnulty J, Ueland K. Cardiovascular physiology. Clin. Obstet. Gynecol. 1981; 24: 693–709.PubMedCrossRefGoogle Scholar
  21. 21.
    Elliot J, Rankin R, Inwood M, Milne J. An arteriovenous malformation in pregnancy: a case report and review of the literature. Am. J. Obstet. Gynecol. 1985; 152: 85–88.Google Scholar
  22. 22.
    Amias AG. Cerebral vascular disease in pregnancy. I: Haemorrhage. J. Obstet. Gynecol. Br. Comm. 1970; 77: 100–120.CrossRefGoogle Scholar
  23. 23.
    Tuttleman R, Gleicher N. Central nervous system hemorrhage complicating pregnancy. Obstet. Gynecol. 1981; 58: 651–656.Google Scholar
  24. 24.
    Henderson C, Torbey M. Rupture of intracranial aneurysm associated with cocaine use during pregnancy. Am. J. Perinatol. 1988; 5: 142–143.PubMedCrossRefGoogle Scholar
  25. 25.
    Donaldson J. Neurologic emergencies in pregnancy. Clin. Obstet. Gynecol. 1991; 18: 199–212.Google Scholar
  26. 26.
    Stern B. Cerebrovascular disease and pregnancy. In: Goldstein P, Stern B (eds.), Neurologic Disorders of Pregnancy, 2nd ed. Mount Kisco, NY: Futura, 1992, pp. 51–84.Google Scholar
  27. 27.
    Dias M, Sekhar L. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990; 27: 855–866.PubMedCrossRefGoogle Scholar
  28. 28.
    Sadasivan B, Malik G, Lee C, Ausman J. Vascular malformations and pregnancy. Surg. Neurol. 1990; 33: 305–313.PubMedCrossRefGoogle Scholar
  29. 29.
    Laidler J, Jackson I, Redfern N. The management of caesarean section in a patient with an intracranial arteriovenous malformation. Anaesthesia 1989; 44: 490–491.PubMedCrossRefGoogle Scholar
  30. 30.
    Young D, Laveno K, Whalley P. Induced delivery prior to surgery for ruptured cerebral aneurysm. Obstet. Gynecol. 1983; 61: 749–752.PubMedGoogle Scholar
  31. 31.
    Robinson J, Hall C, Sedzimir C. Subarachnoid hemorrhage in pregnancy. J. Neurosurg. 1972; 36: 27–33.PubMedCrossRefGoogle Scholar
  32. 32.
    Robinson J, Hall C, Sedzimir C. Arteriovenous malformations, aneurysms, and pregnancy. J. Neurosurg. 1974; 41: 63–70.PubMedCrossRefGoogle Scholar
  33. 33.
    Evans A, Gillogley K. Drug use in pregnancy: obstetric perspectives. Clin. Perinatol. 1991; 18: 23–30.PubMedGoogle Scholar
  34. 34.
    Comarr AE. Observations on menstuation and pregnancy among female spinal cord injury patients. Paraplegia 1966; 3: 263–266.PubMedCrossRefGoogle Scholar
  35. 35.
    Robertson DNS. Pregnancy and labor in the paraplegic. Paraplegia 1972; 10: 209–212.PubMedCrossRefGoogle Scholar
  36. 36.
    Tabsh KMA, Brinkman CR III, Reff RA. Autonomic dysreflexia in pregnancy. Obstet. Gynecol. 1982; 60: 119–125.PubMedGoogle Scholar
  37. 37.
    Naftchi NE, Wooten GF, Lowman EW. Relationship between serum dopaminebeta-hydroxylase activity, catecholamine metabolism, and hemodynamic changes during paroxysmal hypertension in quadriplegia. Circ. Res. 1974; 45: 850–861.CrossRefGoogle Scholar
  38. 38.
    Abouleish E. Hypertension in a paraplegic parturient. Anesthesiology 1980; 53: 348–349.PubMedCrossRefGoogle Scholar
  39. 39.
    Young BK, Katz M, Klein SA. Pregnancy after spinal cord injury: altered maternal and fetal response to labor. Obstet. Gynecol. 1983; 62: 59–63.PubMedGoogle Scholar
  40. 40.
    Watson DW, Downey CO. Epidural anesthesia for labor and delivery of twins of a paraplegic mother. Anesthesiology 1980; 52: 259–261.PubMedCrossRefGoogle Scholar
  41. 41.
    Stitt JA, Marco A, Conklin KA. Obstetric anesthesia for a quadriplegic patient with autonomic hyperreflexia. Anesthesiology 1979; 51: 560–562.CrossRefGoogle Scholar
  42. 42.
    Oppenheimer WM. Pregnancy in paraplegic patients: two case reports. Am. J. Obstet. Gynecol. 1971; 110: 784–786.Google Scholar
  43. 43.
    Epstein MT, Hockaday JM, Hockaday TDR. Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975; 1: 543–547.PubMedCrossRefGoogle Scholar
  44. 44.
    Somerville B. A study of migraine pregnancy. Neurology 1972; 22: 824–828.PubMedCrossRefGoogle Scholar
  45. 45.
    Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22: 355–360.PubMedCrossRefGoogle Scholar
  46. 46.
    Somerville BW. Estrogen-withdrawal migraine. I: Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975; 25: 239–244.PubMedCrossRefGoogle Scholar
  47. 47.
    Somerville BW. Estrogen-withdrawal migraine. II: Attempted prophylaxis by continuous estradiol administration. Neurology 1975; 25: 245–250.PubMedCrossRefGoogle Scholar
  48. 48.
    Bousser MG, Ratinahirana H, Darbois X. Migraine and pregnancy: a prospective study in 703 women after delivery. Neurology;40(Suppl 1):437(abst).Google Scholar
  49. 49.
    Callaghan N. The migraine syndrome in pregnancy. Neurology 1968; 18: 197–201.PubMedCrossRefGoogle Scholar
  50. 50.
    Chanceller MD, Wroe SJ. Migraine occurring for the first time during pregnancy. Headache 1990; 30: 224–227.CrossRefGoogle Scholar
  51. 51.
    Stein GS. Headaches in the first post-partum week and their relationship to migraine. Headache 1981; 21: 201–205.PubMedCrossRefGoogle Scholar
  52. 52.
    Wainsent G, Vol GN. The outcome of pregnancy in women suffering from migraine. Postgrad. Med. J. 1978; 54: 98–102.CrossRefGoogle Scholar
  53. 53.
    Berg G, Hammar M, Moller-Nielsen J, Linden U, Thorblad J. Low back pain during pregnancy. Obstet. Gynecol. 1988; 71: 71–75.PubMedGoogle Scholar
  54. 54.
    Calliet R. Low Back Pain Syndrome. Philadelphia: FA Davis, 1987.Google Scholar
  55. 55.
    Nwuga VCB. Pregnancy and back pain among upper class Nigerian women. Aust. J. Physiother. 1982; 28: 8–11.Google Scholar
  56. 56.
    LaBan MM, Perrin JCS, Latimer FR. Pregnancy and the herniated lumbar disc. Arch. Phys. Med. Rehabil. 1983; 64: 319–321.PubMedGoogle Scholar
  57. 57.
    Fast A, Weiss L, PArikh S, Hertz G. Night backache in pregnancy: hypothetical pathophysiological mechanisms. Am. J. Phys. Med. Rehab. 1989; 68: 227–229.CrossRefGoogle Scholar
  58. 58.
    Reginald RW, Beard RW, Kooner JS. Intravenous dihydroergotamine to relieve pelvic congestion with pain in young women. Lancet 1987; 1: 351–353.CrossRefGoogle Scholar
  59. 59.
    LaBan MM, Wesolowski J. Night pain associated with diminished cardiopulmonary compliance: a concomitant of lumbar spinal stenosis and degenerative spondylolisthesis. Am. J. Phys. Med. Rehabil. 1988; 67: 155–160.PubMedCrossRefGoogle Scholar
  60. 60.
    Melzack R, Scaffelberg D. Low back pain during labor. Am. J. Obstet. Gynecol. 1987; 156: 901–905.PubMedGoogle Scholar
  61. 61.
    Calguneri M, Bird HA, Wright V. Changes in joint laxity occurring during pregnancy. Ann. Rheum. Dis. 1982; 41: 126–128.PubMedCrossRefGoogle Scholar
  62. 62.
    Mantle MJ, Holmes J, Currey HLE Backache in pregnancy. II: Prophylactic influence of back care classes. Rheumatol. Rehabil. 1981; 20: 227–232.PubMedCrossRefGoogle Scholar
  63. 63.
    Hummel P. Changes in Posture During Pregnancy. Philadelphia: WB Saunders, 1987.Google Scholar
  64. 64.
    Hauser WA, Hesdorffer DC. Incidence and prevalence. In: Epilepsy: Frequency, Causes, and Consequences. Maryland: Epilepsy Foundation of America; 1990: 1–53.Google Scholar
  65. 65.
    Stitt SL, Kinnard WJ. The effect of certain progestins and estrogens on the threshold of electrically induced seizure patterns. Neurology 1968; 18: 213–216.PubMedCrossRefGoogle Scholar
  66. 66.
    Wooley DE, Timairas PS. Estrous and circadian periodicity and electroshock convulsions in rats. Am. J. Physiol. 1962; 202: 379–382.Google Scholar
  67. 67.
    Backstrom T, Zetterlund B, Blom S, Romano M. Effects of intravenous progesterone infusions of the epileptic discharge frequency in women with partial epilepsy. Acta. Neurol. Scand. 1984; 69: 240–248.PubMedCrossRefGoogle Scholar
  68. 68.
    Canger R, Avanzini G, Battino D, Bossi L, Franceschetti S, Spina S. Modifications of seizure frequency in pregnant patients with epilepsy: a prospective study. In: Janz D, Bossi L, Dam M, Heige H, Richens A, Schmidt D, (eds.), Epilepsy, Pregnancy and the Child. New York: Raven, 1982, pp. 32–38.Google Scholar
  69. 69.
    Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975; 16: 99–110.PubMedCrossRefGoogle Scholar
  70. 70.
    Bossi L, Assael BM, Avanzini G. Plasma levels and clinical effects of antiepileptic drugs in pregnant epileptic patients and their newborns. In: Johannessen SI, Morselli PL, Pipenger CE, Richens A, Schmidt D, Meinardi H, (eds.), Antiepileptic Therapy: Advances in Drug Monitoring. New York: Raven, 1980, pp. 9–18.Google Scholar
  71. 71.
    Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta. Neurol. Scand. 1976; 54: 321–347.PubMedCrossRefGoogle Scholar
  72. 72.
    Schmidt D, Conyen R, Avanzini G. Change of seizure frequency in pregnant epileptic women. J. Neurol. Neurosurg. Psychiatry 1983; 46: 751–755.PubMedCrossRefGoogle Scholar
  73. 73.
    Eadie MJ, Lander CM, Tyrer JH. Plasma drug level monitoring in pregnancy. Clin. Pharmacokinet. 1977; 2: 427–436.PubMedCrossRefGoogle Scholar
  74. 74.
    Lander CM, Edwards VE, Eadie MJ, Tyrer JH. Plasma anticonvulsant concentrations during pregnancy. Neurology 1977; 27: 71–78.CrossRefGoogle Scholar
  75. 75.
    Dam M, Christiansen J, Munck O, Mygind KJ. Antiepileptic drugs: metabolism in pregnancy. Clin. Pharmacokinet 1979; 4: 53–62PubMedCrossRefGoogle Scholar
  76. 76.
    Yerby MS, Freil PN, McCormick K. Antiepileptic drug disposition during pregnancy. Neurology 1992; 42 (Suppl 5): l2–16.Google Scholar
  77. 77.
    Bayliss EM, Crowley JM, Preece JM, Sylvester PE, Marks V. Influence of folic acid on blood phenytoin levels. Br. Med. J. 1971; 1: 62–64.Google Scholar
  78. 78.
    Strauss RG, Bernstein R. Folic acid and dilantin antagonism in pregnancy. Obstet. Gynecol. 1974; 44: 345–348.PubMedGoogle Scholar
  79. 79.
    Luciano D, Perrin K, Clayton B, Devinsky O. Stress as a seizure precipitant and its relationship to ictal focus. Epilepsia 1992; 33 (Suppl 3): 130.Google Scholar
  80. 80.
    Temkin N, Davis G. Stress as a risk factor for seizures among adults with epilepsy. Epilepsia 1984; 25: 450–456.PubMedCrossRefGoogle Scholar
  81. 81.
    Hoppener RJ, Juyer A, van der Lught PHM. Epilepsy and alcohol: the influence of social alcohol intake on seizures and treatment in epilepsy. Epilepsia 1983; 24: 459–467.PubMedCrossRefGoogle Scholar
  82. 82.
    Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985; 26: 631–635.PubMedCrossRefGoogle Scholar
  83. 83.
    Bjerkdal T, Bahna SL. The course and outcome of pregnancy in women with epilepsy. Acta. Obstet. Gynecol. Scand. 1973; 52: 245–248.CrossRefGoogle Scholar
  84. 84.
    Montouris GD, Feinchel GM, McLain W. The pregnant epileptic. Arch. Neurol. 1979; 36: 601–603.PubMedCrossRefGoogle Scholar
  85. 85.
    Nelson KB, Ellenberg JH. Maternal seizure disorder, outcome of pregnancy and neurologic abnormalities in the children. Neurology 1982; 32: 1247–1254.PubMedCrossRefGoogle Scholar
  86. 86.
    Pearlman MD, Tintinalli JE, Lorenz RP. Blunt trauma during pregnancy. N. Engl. J. Med. 1990; 323: 1609–1613.PubMedCrossRefGoogle Scholar
  87. 87.
    Speidel BD, Meadow BR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972; 2: 839–843.PubMedCrossRefGoogle Scholar
  88. 88.
    Lindhout D, Meinhardi H, Meijer WA, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992; 42 (Suppl 5): 94–100.PubMedGoogle Scholar
  89. 89.
    Hill RM, Berniam WM, Morning MG. Infants exposed in utero to antiepileptic drugs. Am. J. Dis. Child 1974; 127: 645–652.PubMedGoogle Scholar
  90. 90.
    Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birthanomalies. an Italian prospective, controlled study. Neurology 1992; 42 (Suppl 5): 89–93.Google Scholar
  91. 91.
    Hiilesmaa VK. Pregnancy and birth in women with epilepsy. Neurology 1992; 42 (Suppl 5): 8–11.PubMedGoogle Scholar
  92. 92.
    Adams RD, Victor M. Principles of Neurology, 5th ed., New York: McGraw-Hill, 1993.Google Scholar
  93. 93.
    Skraastaad MI, Verwest A. Presymptomatic, prenatal and exclusion testing for Huntington’s disease using seven closely linked DNA markers. Am. J. Med. Genet. 1991; 38: 217–222.CrossRefGoogle Scholar
  94. 94.
    Schoen RE, Sternlieb I. Clinical aspects of Wilson’s disease. Am. J. Gastroenterol. 1990; 85: 1453–1457.Google Scholar
  95. 95.
    Biller J, Swiontoniowski M. Successful pregnancy in Wilson’s disease: a case report and review of the literature. Eur. Neurol. 1985; 24: 306–309.CrossRefGoogle Scholar
  96. 96.
    Scheinberg IH, Sternlieb I. Pregnancy in penicillamine-treated patients with Wilson’s disease. N. Engl. J. Med. 1975; 293: 1300–1302.CrossRefGoogle Scholar
  97. 97.
    Caviness JN, Muenter M. An unusual cause of recurrent chorea. Mov. Disorder 1991; 6: 355–357.CrossRefGoogle Scholar
  98. 98.
    Zegart KN, Schwartz RH. Chorea gravidarum. Obstet. Gynecol. 1968; 32: 24–27.Google Scholar
  99. 99.
    Branch DW. Antiphospholipid antibodies and pregnancy: maternal implications. Semin. Perinatol. 1990; 14: 139–146.PubMedGoogle Scholar
  100. 100.
    Fahn S. Recent concepts in the diagnosis and treatment of dystonias. In: Chokrovert S (ed.), Movement Disorders. Costa Mesa, CA: PMA, 1990, pp. 237–258.Google Scholar
  101. 101.
    American Academy of Neurology. Assessment: the clinical usefulness of botulinum toxin A in treating neurological disorders-report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1990; 40: 1332–1336.CrossRefGoogle Scholar
  102. 102.
    Goodman JDS, Brodie C. Restless leg syndrome in pregnancy. Br. Med. J. 1988; 297: 1101, 1102.Google Scholar
  103. 103.
    Lang AE. Akathisia and restless leg syndrome. In: Jankovic J, Tolosa E, (eds.), Parkinson’s disease and other movement disorders. Baltimore: Urban and Schwartzenberg, 1988, pp. 349–364.Google Scholar
  104. 104.
    Sandyk R, Bamford CR. Estrogen as an adjuvant treatment of Tourette’s syndrome. Pediatr. Neurol. 1987; 3: 122–123.CrossRefGoogle Scholar
  105. 105.
    Schwabe MJ, Konkol RJ. Menstrual cycle-related fluctuations of tics in Tourette’s syndrome. Pediatr. Neurol. 1992; 8: 43–46.CrossRefGoogle Scholar
  106. 106.
    Quinn NP, Marsden CD. Menstrual-related fluctuations in Parkinson’s disease. Mov. Disorder 1986; 1: 85–87.CrossRefGoogle Scholar
  107. 107.
    Bedard P, Langelier P. Oestrogens and the extrapyramidal system. Lancet 1977; 1: 1367–1368.CrossRefGoogle Scholar
  108. 108.
    Cook DG, Klawans HL. Levodopa during pregnancy. Clin. Neuropaharmacol. 1985; 8: 93–95.CrossRefGoogle Scholar
  109. 109.
    Allain H, Bentue-Ferrer D. Pregnancy and parkinsonism: a case report without problems. Clin. Neuropharmacol. 1989; 12: 217–219.CrossRefGoogle Scholar
  110. 110.
    Turkalj I, Braun P. Surveillance of bromocriptine in pregnancy. JAMA 1982; 247: 1589–1591.CrossRefGoogle Scholar
  111. 111.
    Becker DP. Common themes in head injury. In: Becker DP, Gludeman SK (eds.), Textbook of Head Injury. Philadelphia: WB Saunders, 1989, pp. 1–22.Google Scholar
  112. 112.
    Jennett B. Epiplepsy after non-missle head injuries. Chicago: Year-Book Medical Publishers, 1975.Google Scholar
  113. 113.
    Wilberger JE. Emergency care and initial evaluation. In: Cooper PR, ed. Head Injury, 3rd ed. Baltimore: Williams and Wilkins, 1993, pp. 27–41.Google Scholar
  114. 114.
    Hoff WS, D’Anekui LF, Tinkoff GH. Maternal predictors of fetal demise in trauma during pregnancy. Surg. Gynecol. Obstet. 1991; 192: 175–180.Google Scholar
  115. 115.
    Buchsbaum HJ, Cruikshank DP. Postmortem cesarean section. In: Buchsbaum HJ (ed.), Trauma in Pregnancy. Philadelphia, WB Saunders, 1979, pp. 236–249.Google Scholar
  116. 116.
    Frith JA, McLeod JG. Pregnancy and multiple sclerosis. J. Neurol. Neurosurg. Psych. 1988; 51: 495–498.CrossRefGoogle Scholar
  117. 117.
    Bernardi S, Grasso MG, Bertollini R, Orzi F, Fieschi C. The influence of pregnancy on relapses in multiple sclerosis; a cohort study. Acta. Neurol. Scand. 1991; 84: 403–406.CrossRefGoogle Scholar
  118. 118.
    Millar JHD, Allison RS, Cheeseman EA, Merrett JD. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 1959; 82: 417–426.CrossRefGoogle Scholar
  119. 119.
    Schapira K, Poskanzer DC, Newell DJ, Miller H. Marriage, pregnancy and multiple sclerosis. Brain 1966; 89: 419–428.CrossRefGoogle Scholar
  120. 120.
    Ghezzi A, Caputo D. Pregnancy: a factor influencing the course of multiple sclerosis? Eur. Neurol. 1981; 20: 115–117.CrossRefGoogle Scholar
  121. 121.
    Korn-Lubetzki I, Khana E, Cooper G, Abramsky O. Activity of multiple sclerosis during pregnancy and the puerperium. Ann. Neurol. 1984; 16: 129–131.CrossRefGoogle Scholar
  122. 122.
    Birk K, Rudick R. Pregnancy and multiple sclerosis. Arch. Neurol. 1986; 43: 719–726.PubMedCrossRefGoogle Scholar
  123. 123.
    Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch. Neurol. 1990; 47: 738–742.PubMedCrossRefGoogle Scholar
  124. 124.
    Bader AM, Hunt CO, Datta S, Naulty JS, Ostheimer GW. Anesthesia for the obstetric patient with multiple sclerosis. J. Clin. Anest. 1988; 1: 21–24.CrossRefGoogle Scholar
  125. 125.
    Davis RK, Maslow AS. Multiple sclerosis in pregnancy: a review. Obstet. Gynecol. Surv. 1992; 47: 290–296.PubMedCrossRefGoogle Scholar
  126. 126.
    Poser S, Poser W. Multiple sclerosis and gestation. Neurology 1983; 33: 1422–1427.PubMedCrossRefGoogle Scholar
  127. 127.
    Voitk AJ, Mueller JC, Farlinger DE, Johnston RU. Carpal tunnel syndrome in pregnancy. Can. Med. Assoc. J. 1983; 128: 277–281.PubMedGoogle Scholar
  128. 128.
    Ekman-Ordeberg G, Salgeback S, Orderberg S. Carpal tunnel syndrome in pregnancy. Acta. Obstet. Gynecol. Scand. 1987; 66: 233–235.PubMedCrossRefGoogle Scholar
  129. 129.
    Gould JS, Wissinger HA. Carpal tunnel syndrome in pregnancy. South Med. J. 1978; 71: 144–146.PubMedCrossRefGoogle Scholar
  130. 130.
    Wand JS. Carpal tunnel syndrome in pregnancy and lactation. J. Hand. Surg. 1990; 15: 93–95.Google Scholar
  131. 131.
    Donaldson JO. Neuropathy. In: Donaldson JO, (ed.), Neurology of Pregnancy, 2nd ed. Philadelphia: WB Saunders, 1989, pp. 23–59.Google Scholar
  132. 132.
    McCombe PA, McManis PG, Frith JA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculopathy associated with pregnancy. Ann. Neurol. 1987; 21: 102–104.PubMedCrossRefGoogle Scholar
  133. 133.
    Warfield CA. Obturator neuropathy after forceps delivery. Obstet. Gynecol. 1984;64(3 Suppl): 47s,48s.Google Scholar
  134. 134.
    Adelman JU, Goldberg GS, Puckett JD. Postpartum bilateral femoral neuropathy. Obstet Gynecol. 1973; 42: 845–850.PubMedGoogle Scholar
  135. 135.
    Vargo MM, Robinson LR, Nicholas JJ, Rulin MC. Postpartum femoral neuropathy: relic of an earlier era? Arch. Phys. Med. Rehabil. 1990; 71: 591–596.PubMedGoogle Scholar
  136. 136.
    Watson WJ, Beebe JE. Postpartum foot drop: a case report. J. Reprod. Med. 1988; 33: 973, 974.Google Scholar
  137. 137.
    Mumenthaler M, Schliack H. Peripheral Nerve Lesions: Diagnosis and Therapy. New York: Thieme Medical, 1991.Google Scholar
  138. 138.
    Snooks SJ, Swash M, Mathers SE, Henry MM. Effect of vaginal delivery on the pelvic floor: a 5 year follow-up. Br. J. Surg. 1990; 77: 1358–1360.PubMedCrossRefGoogle Scholar
  139. 139.
    Simkin P. Intermittent brachial plexus neuropathy secondary to breast engorgement. Birth 1988; 15: 102, 103.Google Scholar
  140. 140.
    Fu Y-H, Pizzuti A, Fenwick RG. An unstable triplet repeat in a gene related to myotonic dystrophy. Science 1992; 256: 784–789.PubMedCrossRefGoogle Scholar
  141. 141.
    Mahadevan M, Tsilfidis C, Sabourin L. Myotonic dystrophy mutation: an unstable CTG repeat in the 3’ untranslated region of the gene. Science 1992; 255: 1253–1255.PubMedCrossRefGoogle Scholar
  142. 142.
    Harper PS. Myotonic dystrophy, 2nd ed. Philadelphia: WB Saunders, 1989.Google Scholar
  143. 143.
    Sagel J, Distiller LA, Morley JE, Issacs H. Myotonic dystorphica: studies on gonadal function using luteinizng hormone-releasing hormone. J. Clin. Endcrinol. Metab. 1975; 40: 1110–1113.CrossRefGoogle Scholar
  144. 144.
    Hopkins A, Wray S. The effect of pregnancy on dystrophica myotonica. Neurology 1967; 17: 166–168.PubMedCrossRefGoogle Scholar
  145. 145.
    Shore RN, MacLachlan TB. Pregnancy with myotonic dystrophy: course, complications and management. Obstet. Gynecol. 1971; 38: 448–454.PubMedGoogle Scholar
  146. 146.
    Hook R, Anderson EF, Noto P. Anesthetic management of a parturient with myotonic dystrophy. Anesthesiology 1975; 43: 689–692.PubMedCrossRefGoogle Scholar
  147. 147.
    Webb D, Muir I, Faulker J, Johnson G. Myotonia dystrophica: obstetric complications. Am. J. Obstet. Gynecol. 1978; 132: 265–270.PubMedGoogle Scholar
  148. 148.
    Mitchell MM, Ali HH, Savarese JJ. Myotonia and neuromuscular blocking agents. Anesthesiology 1978; 49: 44–48.PubMedCrossRefGoogle Scholar
  149. 149.
    Thiel RE. The myotonic response to suxamethonium Br. J. Anesth. 1967; 39: 815–820.CrossRefGoogle Scholar
  150. 150.
    Poulton J. Congenital myotonic dystrophy and mtDNA. Am. J. Hum. Genet. 1992; 50: 651, 652.Google Scholar
  151. 151.
    Gardiner CF. A case of myotonia congenita. Arch. Pediatr. 1901;18:925–928. 152 Hakim CA, Thomlinson J. Myotonia congenita in pregnancy. J. Obstet. Gynaecol. Br. Commonweal. 1969; 295: 543, 544.Google Scholar
  152. 153.
    Clemens PR, Fenwick RG, Chamberlain JS. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families using dinucleotide repeat polymorphisms. Am. J. Hum. Genet. 1991; 49: 951–960.PubMedGoogle Scholar
  153. 154.
    Hoffman EP, Arahata K, Minetti C. Dystophinopathy in isolated cases of myopathy in females. Neurology 1992; 42: 967–975.PubMedCrossRefGoogle Scholar
  154. 155.
    Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates and diagnostic value. Neurology 1976; 26: 1054–1059.PubMedCrossRefGoogle Scholar
  155. 156.
    Can SC, Gilchrist JM, Abuelo D, Clark D. Antenatal treatment of myasthenia gravis. Obstet. Gynecol. 1991; 78: 485–489.Google Scholar
  156. 157.
    Levine SE, Keesey JC. Successful plasmapheresis for fulminant myastenia gravis during pregnancy. Arch. Neurol. 1986; 43: 197, 198.Google Scholar
  157. 158.
    Watson WJ, Katz VL, Bowes WA. Plasmapheresis during pregnancy. Obstet. Gynecol. 1990; 76: 451–457.PubMedGoogle Scholar
  158. 159.
    Miller RG, Milner-Brown HS, Mirka A. Prednisone-induced worsening of neuromuscular function in myasthenia gravis. Neurology 1986; 36: 729–732.PubMedCrossRefGoogle Scholar
  159. 160.
    Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann. NY Acad. Sci. 1966; 135: 496–503.PubMedCrossRefGoogle Scholar
  160. 161.
    Ip MSM, So SY, Lam WK, Tang LCH, Mok CK. Thymectomy in myasthenia gravis during pregnancy. Postgrad. Med. J. 1986; 62: 473, 474.Google Scholar
  161. 162.
    Argov Z, Mastaglia FL. Disorders of neuromuscular transmission caused by drugs. N. Engl. J. Med. 1979; 301: 409–413.PubMedCrossRefGoogle Scholar
  162. 163.
    Kaeser HE. Drug-induced myasthenic syndromes. Acta Neurol Scand 1984; 70 (Suppl): 39–47.Google Scholar
  163. 164.
    Plauche WC. Myasthenia gravis in mothers and their newborn. J. Obstet. Gynaecol. Br. Commonweal. 1969; 76: 323–329.CrossRefGoogle Scholar
  164. 165.
    Donaldson JO. Neurology of pregnancy, 2nd ed. Philadelphia: WB Saunders, 1989, pp. 61–85.Google Scholar
  165. 166.
    Rolbin SH, Levinson G, Shnider SM. Anesthetic considerations for myasthenia gravis and pregnancy. Anest. Analg. 1978; 57: 441–443.CrossRefGoogle Scholar
  166. 167.
    Keesey J, Lindstrom J, Cokely H. Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. N. Engl. J. Med 1977; 296: 55–57.PubMedGoogle Scholar
  167. 168.
    Namba T, Brown SB, Grob D. Neonatal myasthenia gravis: report of two cases and review of the literature. Pediatrics 1970; 45: 488–504.PubMedGoogle Scholar
  168. 169.
    Eymard B, Morel E, Dulac O. Myasthenia and pregnancy: a clinical and immunologic study of 42 cases (21 neonatal myasthenia gravis). Rev. Neurol. 1989; 145: 696–701.PubMedGoogle Scholar
  169. 170.
    Ditzian-Kadanoff R, Reonhard JD, Thomas C, Segal AS.Polymyositis with myoglobinuria in pregnancy: a report and review of the literature. J. Rheumatol. 1988; 15: 513, 514.Google Scholar
  170. 171.
    Ishii N, Ono H, Kawaguchi T, Nakajima H. Dermatomyositis and pregnancy• case report and review of the literature. Dermaologica 1991; 183: 146–149.CrossRefGoogle Scholar
  171. 172.
    Tsai A, Lindheimer MD, Lamberg SI. Dermatonyositis complicating pregnancy. Obstet. Gynecol. 1973; 41: 570–573.PubMedGoogle Scholar
  172. 173.
    Katz AL. Another case of polymyositis in pregnancy. Arch. Intern. Med. 1980; 140: 1123.PubMedCrossRefGoogle Scholar
  173. 174.
    Gutierrez G, Dagnino R, Mintz G. Polymyositis-dermatomyositis and pregnancy. Arthritis Rheum. 1984; 27: 291–294.PubMedCrossRefGoogle Scholar
  174. 175.
    DiMauro S, Papadimitriou A. Carnitine palmitotransferase deficiency. In: Engel AG, Banker BQ, (eds.), Myology, Vol. 2. New York, McGraw-Hill, 1986, pp. 1698, 1699.Google Scholar
  175. 176.
    Kaplan RF, Kellner KR. More on malignant hyperthermia during delivery. Am. J. Obstet. Gynecol. 1985; 152: 608, 609.Google Scholar
  176. 177.
    Liebenschutz F, Mai C, Pickerodt VWA. Increased carbon dioxide production in two patients with malignant hyperthermia and its control by dantrolene. Br. J. Anaesth. 1979; 51: 899–903.PubMedCrossRefGoogle Scholar
  177. 178.
    Lips FJ, Newland M, Dutton G. Malignant hyperthermia triggered by cyclopropane during cesarean section. Anesthesiology 1982; 56: 144–146.PubMedCrossRefGoogle Scholar
  178. 179.
    Morgan-Hughes JA. The mitochonddrial myopathies. In: Engel, AG, Banker BQ, (eds.), Myology, Vol. 2. New York: McGraw-Hill, 1986, pp. 1709–1743.Google Scholar
  179. 180.
    Angelini C, Govoni E, Bragaglia M, Vergani L. Carnitine deficiency: acute posparturn crisis. Ann. Neurol. 1978; 4: 558–561.PubMedCrossRefGoogle Scholar
  180. 181.
    Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J. Clin. Oncol. 1988; 5: 543–551.Google Scholar
  181. 182.
    Ruderman NB, Hall TC. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 1965; 18: 298–306.PubMedCrossRefGoogle Scholar
  182. 183.
    Shapiro WR, Posner JB. Corticosteroid hormones. Arch. Neurol. 1974; 30: 217–221.Google Scholar
  183. 184.
    Donaldson JO. Neurology of Pregnancy, 2nd ed. Philadelphia: WB Saunders, 1989, pp. 185–216.Google Scholar
  184. 185.
    Kempers RD, Miller RH. Management of pregnancy associated with brain tumors. Am. J. Obstet. Gynecol. 1963; 87: 858–864.PubMedGoogle Scholar
  185. 186.
    Finfer SR. Management of labor and delivery in patients with intracranial neoplasms. Br. J. Anaesth. 1991; 67: 784–787.Google Scholar
  186. 187.
    Gast MJ, Grubb RL Jr, Strickler RC. Maternal hydrocephalus and pregnancy. Obstet. Gynecol. 1983; 62: 292–294.Google Scholar
  187. 188.
    Wisoff JH, Kratzert KJ, Handwerker SM, Young BK, Epstein F. Pregnancy in patients with cerebrospinal fluid shunts: report of a series and review of the literature. Neurosurgery 1991; 29: 827–831.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Charles E. Argoff

There are no affiliations available

Personalised recommendations